No records
|
529 |
Kario K., Hoshide S., Chia Y.-C., Buranakitjaroen P., Siddique S., Shin J., Turana Y., Park S., Tsoi K., Chen C.-H., Cheng H.-M., Fujiwara T., Li Y., Huynh V.M., Nagai M., Nailes J., Sison J., Soenarta A.A., Sogunuru G.P., Sukonthasarn A., Tay J.C., Teo B.W., Verma N., Wang T.-D., Zhang Y., Wang J.-G. |
7102633390;6603859769;57204080905;6603376248;57210091066;54791393300;56083326000;8556278400;16065259000;7501963868;57026688600;57212076752;55931488300;57222327024;23498874000;57204676117;36764809200;6507634613;26428524900;12793132900;24330212600;23570166200;7102496979;7405566618;56183109800;57211730247; |
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
411 |
421 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103146577&doi=10.1111%2fjch.14128&partnerID=40&md5=d75ac783dd0b799133a4ba32d9d8a571 |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Punjab Medical Center, Lahore, Pakistan; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Centre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Department of Internal Medicine, General Medicine and Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan; Department of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines; Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Physiology, King George's Medical University, Lucknow, India; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Fujiwara, T., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Li, Y., Centre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Huynh, V.M., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Nagai, M., Department of Internal Medicine, General Medicine and Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan; Nailes, J., Department of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines; Sison, J., Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Sogunuru, G.P., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Sukonthasarn, A., Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Zhang, Y., Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Hypertension is an important public health issue due to its association with a number of serious diseases, including cardiovascular disease and stroke. The importance of evaluating hypertension taking into account different blood pressure (BP) profiles and BP variability (BPV) is increasingly being recognized, and is particularly relevant in Asian populations given the specific features of hypertension in the region (including greater salt sensitivity and a high rate of nocturnal hypertension). Ambulatory BP monitoring (ABPM) is the gold standard for diagnosing hypertension and assessing 24-hour BP and provides data on several important parameters that cannot be obtained using any other form of BP measurement. In addition, ABPM parameters provide better information on cardio- and cerebrovascular risk than office BP. ABPM should be used in all patients with elevated BP, particularly those with unstable office or home BP, or who are suspected to have white-coat or masked hypertension. ABPM is also an important part of hypertension diagnosis and monitoring in high-risk patients. ABPM needs to be performed using a validated device and good practice techniques, and has a role both in hypertension diagnosis and in monitoring the response to antihypertensive therapy to ensure strict BP control throughout the 24-hour period. Use of ABPM in clinical practice may be limited by cost and accessibility, and practical education of physicians and patients is essential. The ABPM evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for ABPM in Asia. © 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC |
ambulatory blood pressure monitoring; blood pressure control; clinical practice; guidelines; hypertension |
angiotensin receptor antagonist; antihypertensive agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; antihypertensive agent; atherosclerosis; blood pressure monitoring; blood pressure regulation; blood pressure variability; brain hemorrhage; cardiovascular risk; circadian rhythm; cognitive defect; comorbidity; coronary artery disease; cost control; diastolic blood pressure; diastolic dysfunction; disease association; drug efficacy; health care access; heart left ventricle hypertrophy; high risk patient; human; low risk patient; masked hypertension; microangiopathy; prevalence; prognosis; reimbursement; Review; sensitivity and specificity; sleep disordered breathing; systolic blood pressure; telemedicine; treatment response; white coat hypertension; Asia; blood pr |
John Wiley and Sons Inc |
15246175 |
|
33319412 |
Review |
Q2 |
909 |
5078 |
|
|
532 |
Hoshide S., Kario K., Chia Y.-C., Siddique S., Buranakitjaroen P., Tsoi K., Tay J.C., Turana Y., Chen C.-H., Cheng H.-M., Huynh V.M., Park S., Soenarta A.A., Sogunuru G.P., Wang T.-D., Wang J.-G. |
6603859769;7102633390;57204080905;57210091066;6603376248;16065259000;24330212600;56083326000;7501963868;57026688600;57222327024;8556278400;6507634613;26428524900;7405566618;57211730247; |
Characteristics of hypertension in obstructive sleep apnea: An Asian experience |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
489 |
495 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102268392&doi=10.1111%2fjch.14184&partnerID=40&md5=801bd49c61521ab9e90707d5d59d804b |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Punjab Medical Center, Lahore, Pakistan; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Hypertension, Shanghai Key Laboratory of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Huynh, V.M., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Sogunuru, G.P., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Wang, J.-G., Department of Hypertension, Shanghai Key Laboratory of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Obstructive sleep apnea (OSA) is a risk of hypertension and is associated with cardiovascular disease (CVD) incidence. In Asian countries, the prevalence of OSA is high, as in Western countries. When blood pressure (BP) is evaluated in OSA individuals using ambulatory BP monitoring (ABPM), the BP phenotype often indicates abnormal BP variability, such as increased nighttime BP or abnormal diurnal BP variation, that is, non-dipper pattern, riser pattern, and morning BP surge, and all these conditions have been associated with increased CVD events. Asians have a higher prevalence of increased nighttime BP or morning BP surge than Westerners. Therefore, this review paper focused on OSA and hypertension from an Asian perspective to investigate the importance of the association between OSA and hypertension in the Asian population. Such abnormal BP variability has been shown to be associated with progression of arterial stiffness, and this association could provoke a vicious cycle between abnormal BP phenotypes and arterial stiffness, a phenomenon recognized as systemic hemodynamic atherothrombotic syndrome (SHATS). OSA may be one of the background factors that augment SHATS. An oxygen-triggered nocturnal oscillometric BP measurement device combined with a pulse oximeter for continuous SpO2 monitoring could detect BP variability caused by OSA. In addition to treating the OSA, accurate and reliable detection and treatment of any residual BP elevation and BP variability caused by OSA would be necessary to prevent CVD events. However, more detailed detection of BP variability, such as beat-by-beat BP monitoring, would further help to reduce CV events. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
blood pressure variability; hypertension; obstructive sleep apnea |
amlodipine; antihypertensive agent; atenolol; enalapril; hydrochlorothiazide; losartan; aerobic exercise; antihypertensive therapy; apnea hypopnea index; Asia; Asian; blood pressure; body mass; continuous positive airway pressure; follow up; human; hypertension; kidney denervation; lifestyle modification; obesity; polysomnography; primary hyperaldosteronism; Review; sleep disordered breathing; Asian continental ancestry group; blood pressure monitoring; hypertension; sleep disordered breathing; Asia; Asian Continental Ancestry Group; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Sleep Apnea, Obstructive |
John Wiley and Sons Inc |
15246175 |
|
33705599 |
Review |
Q2 |
909 |
5078 |
|
|
537 |
Huang J.-F., Li Y., Shin J., Chia Y.-C., Sukonthasarn A., Turana Y., Chen C.-H., Cheng H.-M., Ann Soenarta A., Tay J.C., Wang T.-D., Kario K., Wang J.-G., the HOPE Asia Network |
57215634442;55931488300;54791393300;57204080905;12793132900;56083326000;7501963868;57026688600;56545726300;24330212600;7405566618;7102633390;57211730247; |
Characteristics and control of the 24-hour ambulatory blood pressure in patients with metabolic syndrome |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
450 |
456 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101762609&doi=10.1111%2fjch.14229&partnerID=40&md5=e26837f3a812c95b88ec3427586cac58 |
Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Internal Medicine, Cardiology Division, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Department of Internal Medicine, Cardiovascular Center and Division of Cardiology, National Taiwan University Hospital, Taipei City, Taiwan; Department of Internal Medicine, Division of Hospital Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Huang, J.-F., Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Li, Y., Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Sukonthasarn, A., Department of Internal Medicine, Cardiology Division, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Ann Soenarta, A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Wang, T.-D., Department of Internal Medicine, Cardiovascular Center and Division of Cardiology, National Taiwan University Hospital, Taipei City, Taiwan, Department of Internal Medicine, Division of Hospital Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Kario, K., Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Wang, J.-G., Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; the HOPE Asia Network |
Asian countries are facing an increasing prevalence of metabolic syndrome (MetS), which may aggravate the burden of cardiovascular diseases in this region. MetS is closely associated with ambulatory blood pressure (BP). Patients with MetS, compared to those without, had a twofold higher risk of new-onset office, home, or ambulatory hypertension. Furthermore, the risk of new-onset MetS in patients with white-coat, masked and sustained hypertension was also doubled compared to normotensives. High-risk masked hypertension and blunted nighttime BP dipping are common in patients with MetS, suggesting perfect 24-hour BP control with long-acting antihypertensive drugs and early initiation of combination therapy might be especially important for patients with MetS. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
ambulatory blood pressure monitoring; antihypertensive treatment; masked hypertension; metabolic syndrome; non-dipping |
amlodipine; antidiabetic agent; antihypertensive agent; hydrochlorothiazide; hydroxymethylglutaryl coenzyme A reductase inhibitor; losartan; ramipril; sodium glucose cotransporter 2 inhibitor; zofenopril; abdominal obesity; blood pressure monitoring; clinical feature; diabetes mellitus; disease association; disease control; high risk patient; human; hyperglycemia; hypertension; metabolic syndrome X; prevalence; Review; risk assessment; waist circumference; white coat hypertension; Asia; blood pressure; blood pressure monitoring; hypertension; masked hypertension; metabolic syndrome X; Asia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Masked Hypertension; Metabolic Syndrome |
John Wiley and Sons Inc |
15246175 |
|
33629806 |
Review |
Q2 |
909 |
5078 |
|
|
540 |
Chia Y.-C., Turana Y., Sukonthasarn A., Zhang Y., Shin J., Cheng H.-M., Tay J.C., Tsoi K., Siddique S., Verma N., Buranakitjaroen P., Sogunuru G.P., Nailes J., Van Minh H., Park S., Teo B.W., Chen C.-H., Wang T.-D., Soenarta A.A., Hoshide S., Wang J.-G., Kario K., the Hypertension Cardiovascular Outcome Prevention, Evidence (HOPE) Asia Network |
57204080905;56083326000;12793132900;56183109800;54791393300;57026688600;24330212600;16065259000;57210091066;7102496979;6603376248;26428524900;57204676117;57211946145;8556278400;23570166200;7501963868;7405566618;6507634613;6603859769;57211730247;7102633390; |
Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE-Asia Network |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
422 |
434 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101598138&doi=10.1111%2fjch.14226&partnerID=40&md5=3615334261cf54af8eb6d23b4967e99b |
Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Division of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Department of General Medicine, Tan Tock Seng Hospital, Singapore; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Punjab Medical Center, Lahore, Pakistan; Department of Physiology, King George's Medical University, Lucknow, India; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Chia, Y.-C., Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Sukonthasarn, A., Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Zhang, Y., Division of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Sogunuru, G.P., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Nailes, J., University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Van Minh, H., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore; Chen, C.-H., Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; the Hypertension Cardiovascular Outcome Prevention, Evidence (HOPE) Asia Network |
Guidelines on the management of hypertension have been developed by various professional bodies and institutions to primarily address the issues of diagnosis, treatment, and control in order to rationalize and improve the management of hypertension. Hypertension guidelines across the world have recently been updated following the new and controversial lower blood pressure threshold of ≥130/80 mmHg for the diagnosis of hypertension adopted by the Americans. While there are differences between the major as well as between the Asian national guidelines, there were also many similarities. This paper discusses and highlights the differences and similarities between the major international guidelines of the American College of Cardiology/American Heart Association, of the European Society of Cardiology/European Society of Hypertension, and of the International Society of Hypertension and also compares them with the Asian guidelines. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
Asian countries; diagnosis; guidelines; HOPE-Asia Network; hypertension; target blood pressure |
angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; Asia; blood pressure measurement; blood pressure monitoring; cardiovascular risk; cerebrovascular accident; chronic kidney failure; chronology; coronary artery disease; decision making; diabetes mellitus; Europe; geographic distribution; geriatrics; heart failure; Hong Kong; human; hypertension; India; Indonesia; Malaysia; medical society; multiple sclerosis; Pakistan; Philippines; practice guideline; Review; risk assessment; Singapore; Taiwan; Thailand; United States; Viet Nam; blood pressure; cardiology; hypertension; hypotension; American Heart Association; Asia; Blood Pressure; Cardiology; Humans; Hypertension; Hypotension; Uni |
John Wiley and Sons Inc |
15246175 |
|
33634570 |
Review |
Q2 |
909 |
5078 |
|
|